Lill Ljung

Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies

Karin Hägerbrand, Laura A. Varas, Adnan Deronic et al. · Journal for ImmunoTherapy of Cancer · 2022 · 26 citations · Full text

Life Sciences, Immunology, Oncology +17

Purification of truncated and mutated Chemotaxis Inhibitory Protein of Staphylococcus aureus—an anti-inflammatory protein

Erika Gustafsson, Cecilia Forsberg, Karin Haraldsson et al. · Protein Expression and Purification · 2008 · 14 citations

Life Sciences, Immunology, Microbiology +12

Directed evolution of chemotaxis inhibitory protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodies

Erika Gustafsson, Anna Rosén, Karin Barchan et al. · Protein Engineering Design and Selection · 2009 · 13 citations · Full text

Engineering, Biotechnology, Immunology +17

The Bispecific Tumor Antigen-Conditional 4–1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies

Michelle H. Nelson, Sara Fritzell, Robert E. Miller et al. · Molecular Cancer Therapeutics · 2022 · 11 citations · Full text

Medicine, Immunology, Oncology +17